News Releases
-
News Releases
Total baseline value for Emergent is approximately $90 million USD, further expanding the collaboration between the companies, which began in February 2021.
Released on 01.25.2022
-
News Releases
Lenzilumab™ is currently in a Phase 3 clinical trial evaluating patients hospitalized with COVID-19. Humanigen intends to file for EUA first quarter of 2021.
Released on 03.04.2021
-
News Releases
to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding
Released on 07.08.2020
-
News Releases
for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate
Released on 07.06.2020
-
News Releases
in Canton Site and Expand Viral Vector and Gene Therapy Capability
Released on 06.18.2020
-
News Releases
for AstraZeneca’s COVID-19 Vaccine Candidate
Released on 06.11.2020
-
News Releases
in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing
Released on 06.01.2020
-
News Releases
for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19
Released on 04.23.2020
-
News Releases
to Expedite Development of Plasma-Derived Therapy for COVID-19
Released on 04.02.2020
-
News Releases
with Vaxart for their Experimental Oral Vaccine Candidate for Coronavirus Disease
Released on 03.18.2020
-
News Releases
for the Treatment and Prevention of Coronavirus Disease
Released on 03.11.2020
-
News Releases
With Novavax for Experimental Vaccine Candidate for Coronavirus Disease
Released on 03.10.2020
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
United States
Company Description
Emergent offers biopharmaceutical companies a strategic and reliable solution to their clinical and commercial supply chain needs. As a committed and reliable CDMO partner, we have the scientific and regulatory compliance experience and cGMP manufacturing capabilities to support complex and challenging programs.
Contract Service Directory
- Accelerated Stability Studies
- Analytical Laboratory Services
- Analytical Methods Development
- Analytical Validation Studies
- Assay Development
- Biologics Manufacturing
- Biologics Process Development
- Biosimilars
- Clinical Trials, Phase I
- Clinical Trials, Phase II
- Clinical Trials, Phase III
- Clinical Trials, Phase IV
- CMC (Chemistry, Manfacturing & Controls)
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Downstream Processing
- Filling, Syringe
- Filling, Vial
- Gene Therapy & Testing Protocols
- Lot Release Testing
- Lyophilization
- Manufacturing, Aseptic Fill/Finish
- Manufacturing, Biologics
- Manufacturing, Clinical Trials Supply
- Manufacturing, Dose Form, Sterile
- Manufacturing, Injectables
- Manufacturing, Liquids
- Manufacturing, Lyophilized Products
- Manufacturing, Oligonucleotides
- Manufacturing, Parenterals, Small Volume
- Manufacturing, Peptides
- Manufacturing, Proteins
- Manufacturing, Syringes, Pre-filled
- Manufacturing, Vaccines
- Manufacturing, Veterinary
- Packaging, Injectables
- Parenterals, Syringe Filling
- Parenterals, Vial Filling
- Process Development/Scale-Up Services
- Process Validation Studies
- Purification
- QA/QC
- Stability Studies
- Stability, ICH
- Sterile Filling
- Sterility Testing
- Syringe Filling
- Technology Transfer
- Validation, Clinical
- Validation, Manufacturing